Basics Climb Bio, Inc. Common Stock IPO Date: August 10, 2021 Sector: Healthcare Industry: Biotech Market Cap: $161.96M Activated in VL: True Average Daily Range Avg Daily Range: $0.27 | 4.47% Avg Daily Range (30 D): $0.08 | 4.14% Avg Daily Range (90 D): $0.06 | 3.68% Institutional Daily Volume Avg Daily Volume: .18M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .31M Trade Size Avg Trade Size (Sh.): 138 Avg Trade Size (Sh.) (30 D): 209 Avg Trade Size (Sh.) (90 D): 176 Institutional Trades Total Inst.Trades: 53 Avg Inst. Trade: $1.97M Avg Inst. Trade (30 D): $2.68M Avg Inst. Trade (90 D): $1.62M Avg Inst. Trade Volume: .4M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $4.19M Avg Closing Trade (30 D): $2.68M Avg Closing Trade (90 D): $2.68M Avg Closing Volume: 648.35K     News Aug 25, 2025 @ 6:41 PM UPDATE – Climb Bio to Present at Upcoming S... Source: Carlo Tanzi, Ph.D. May 19, 2025 @ 8:34 PM Climb Bio Reports Inducement Grant Under Nasdaq Li... Source: Na Oct 11, 2024 @ 4:30 PM Climb Bio Announces Abstract Selected for Presenta... Source: N/A Oct 4, 2024 @ 11:00 AM Climb Bio to Present at William Blair’s Upc... Source: N/A Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.53 $-.13 $-.31 Diluted EPS $-.53 $-.13 $-.31 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -46.76M $ -8.67M $ -20.78M Operating Income / Loss $ -56.34M $ -10.68M $ -23.02M Cost of Revenue $ $ $ Net Cash Flow $ -135.96M $ M $ M PE Ratio